APS phenotypes | Associated aPLs and clinical manifestations | O.R. |
---|---|---|
Arterial thrombosis | > 7 any aPLsa | 4.1 [CI 95% 1.9–96] |
aPT IgG | 2.3 [CI 95% 1.1–5.1] | |
Primary APS | 2.2 [CI 95% 1.1–4.5] | |
CNS manifestations | aPT + aPG + aPI and aAN (IgG) | 2.6 [CI 95% 1.1–6.3] |
Venous thrombosis | aP-acid IgM | 0.3 [CI 95% 0.1–0.9] |
Event free period > 3 years from last thrombotic events | aPI IgG | 3 [CI 95% 1.08–8.1] |
aAN IgG | 3.4 [CI 95%1.08–10.9] | |
Pregnancy morbidity | aCL IgG and aPS IgG | 2.9 [CI 95% 1.3–6.5] |
anti-AN IgG | 2.8 [CI 95% 1.02–8] | |
Arterial thrombosis | 3.3 [CI 95% 1.5–7.2] | |
CNS manifestations | 3.9 [CI 95% 1.7–9] | |
Secondary APS | 2.3 [CI 95%1.03–5.16] |